Corrigendum: Telmisartan Prevents Alveolar Bone Loss by Decreasing the Expression of Osteoclasts Markers in Hypertensive Rats With Periodontal Disease (Front. Pharmacol., (2020), 11, (579926), 10.3389/fphar.2020.579926)

0Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.

Abstract

In the original article, there was a mistake in Figure 3 as published. On Figure 3 panel F, an error was made when assembling the representative imagens on the board, and the same image was included twice for the SHR Control group and SHR Telm + PD group. The correct representative image for the SHR Control group was included and the corrected Figure 3 appears below. The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated. (Figure presented.).

Cite

CITATION STYLE

APA

Brito, V. G. B., Patrocinio, M. S., Linjardi, M. C., Emanuelli Alves Barreto, A., Frasnelli, S. C. T., Lara, V., … Oliveira, S. H. P. (2021, February 19). Corrigendum: Telmisartan Prevents Alveolar Bone Loss by Decreasing the Expression of Osteoclasts Markers in Hypertensive Rats With Periodontal Disease (Front. Pharmacol., (2020), 11, (579926), 10.3389/fphar.2020.579926). Frontiers in Pharmacology. Frontiers Media S.A. https://doi.org/10.3389/fphar.2020.635927

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free